Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04074304
Other study ID # 20-11022933 frmrly 19-04020138
Secondary ID 1K76AG059997-01A
Status Completed
Phase N/A
First received
Last updated
Start date May 18, 2021
Est. completion date November 3, 2021

Study information

Verified date March 2022
Source Weill Medical College of Cornell University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

With the growth of hospice, older adults have the opportunity to receive home-based care aimed at reducing suffering and focusing on quality of life at the end of life. While use of technology and educational videos has yet to be fully developed, structured, and evaluated in home hospice care, it has shown promise to improve care in other settings. Therefore, this study aims to develop and evaluate a multi-component technology-based care intervention, i.e., Improving Home hospice Management of End of life issues through technology (I-HoME), that focuses on assessing and addressing patient symptoms and caregiver burden in the home hospice setting through synchronous live video visits and educational videos. The aim of the first phase of the project is to employ an iterative user-centered design process to develop I-HoME for home hospice patients and their caregivers prior to implementation.


Recruitment information / eligibility

Status Completed
Enrollment 12
Est. completion date November 3, 2021
Est. primary completion date November 3, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 110 Years
Eligibility Inclusion Criteria: - Home hospice providers (N=10) and family caregivers (N=10) must be English speaking, 18 years of age or older, not blind, and either providing or receiving home hospice care. Home hospice patients (N=10) must be English speaking, 65 years of age or older, not blind, and enrolled in home hospice care. Exclusion Criteria: - Patients with a terminal diagnosis of dementia or patients who have cognitive impairment and unable to sign a written informed consent will be excluded.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
I-HoME
A multi-component technology-based care intervention.

Locations

Country Name City State
United States The Visiting Nurse Service of New York New York New York

Sponsors (3)

Lead Sponsor Collaborator
Weill Medical College of Cornell University National Institute on Aging (NIA), Visiting Nurse Service of New York

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Participants' experience using the intervention as measured by the I-HoME User-centered design questionnaire A questionnaire consisting of open ended questions asking participants to provide feedback and their thoughts about the I-HoME intervention. The responses gathered are not scored, but qualitative analysis will be performed to identify issues that will be used to make revisions to the I-HoME intervention before starting phase 2 of the project. 1 day